Patterns of Haemophilus influenzae type b Invasive Disease in New York State, 1987 to 1991: The Role of Vaccination Requirements for Day-Care Attendance

PEDIATRICS ◽  
1994 ◽  
Vol 94 (6) ◽  
pp. 1014-1016
Author(s):  
Elaine E. Schulte ◽  
Guthrie S. Birkhead ◽  
Stan F. Kondracki ◽  
Dale L. Morse

Haemophilus influenzae type b (Hib) is the most common cause of bacterial meningitis in young children and is a major cause of other invasive bacterial disease.1 The case fatality rate for Hib meningitis is 1.0% to 3.4%.2,3 Also, 14% of meningitis cases result in persisting neurologic sequelae and 10% to 11% result in sensorineural hearing loss.4,5 With the introduction of Hib vaccines in 1985, what was once a potentially devastating disease is now preventable by vaccination.6 The risk of Hib in day-care centers (DCCs) is highest for younger children (≤23 months of age), during the first month of enrollment in day care, and for those children who attend larger day-care centers as opposed to home day-care settings.7 The incidence of Hib disease is higher for blacks, Hispanics, native Alaskans, American Indians, and children of lower socioeconomic status.8 Increasing enrollment in licensed DCCs throughout the country has provided an opportunity, through entrance requirements, to ensure that these children receive public health preventive measures such as vaccinations. Most states have laws requiring certain vaccinations before entry into DCCs; however, many states do not have a specific DCC entry requirement for Hib vaccination.9 The purposes of this article are to examine patterns of Hib incidence in New York State by gender, race, and age and to evaluate Hib disease within the DCC setting in New York State in relation to changing Hib vaccine requirements for DCCs. METHODS We conducted a retrospective study of invasive Hib disease in New York State outside New York City.

PEDIATRICS ◽  
1979 ◽  
Vol 63 (3) ◽  
pp. 397-401
Author(s):  
Dan M. Granoff ◽  
Janet Gilsdorf ◽  
Charles Gessert ◽  
Millie Basden

Two cases of invasive Haemophilus influenzae type B disease (meningitis and cellulitis) occurred during a 60-day period among 69 children (median age 18 months) attending a day care center in Fresno, Calif. Nasopharyngeal colonization rates for H influenzae type B were 49% in the children, 8% in family contacts of culture-positive children, and 0% in staff. Colonization by H influenzae type B was infrequent in two control populations of children: those attending day care centers in Fresno without known H influenzae type B disease, and healthy children not enrolled in day care centers. The isolates from the children in the index day care center were inhibited in vitro by low concentrations of trimethoprim-sulfamethoxazole, but therapy with this combination for seven to ten days was ineffective in eliminating H influenzae type B carriage in 73% of 26 treated children. In a second clinical trial, treatment for four days with rifampin eradicated H influenzae type B carriage in 14 of 16 culture-positive individuals, whereas carriage persisted in 6 of 7 children whose families initially declined rifampin therapy (X2c; = 8.5, P .004). When systemic H influenzae type B infection occurs in a closed population of young children, the risk of serious illness among contacts may be appreciably higher than in similar age children in the general population. Our data indicate that rifampin is effective in this clinical setting, and support the need for a larger, controlled clinical trial.


PEDIATRICS ◽  
1986 ◽  
Vol 78 (5) ◽  
pp. 939-941
Author(s):  
BARRY DASHEFSKY ◽  
ELLEN WALD ◽  
KARL LI

Haemophilus influenzae type b (HIB) is the most common cause of serious bacterial disease in children in the United States with 20,000 cases occurring annually. In 1979, it was convincingly reported that this pathogen could spread in households, resuiting in a significantly increased risk of subsequent disease in household contacts.1 Confusion resulting from changing recommendations of the Committee on Infectious Diseases of the American Academy of Pediatrics regarding rifampin prophylaxis for HIB disease2,3 and the recent advent of the HIB vaccine4 prompt this commentary on the management of contacts of children with invasive HIB disease with special emphasis on the day-care setting.


PEDIATRICS ◽  
1987 ◽  
Vol 79 (3) ◽  
pp. 445-446
Author(s):  
GEORGE G. STERNE

Children in day care, like their home-reared peers, frequently become ill. Whether they are sick more frequently than those not in day care has been a question difficult to resolve because of the problem of appropriate control studies. Many pediatricians are convinced that this is so. There are data that infections due to certain specific agents including hepatitis A, Haemophilus influenzae type B, and Giardia lamblia occur more often in day-care center attendees. Clinical entities such as diarrhea, meningitis, and otitis media have also been shown to be more common in day-care center attendees. A recent review in Pediatrics1 provides a good overview of the problem.


1990 ◽  
Vol 9 (5) ◽  
pp. 326-332 ◽  
Author(s):  
I. ANDERSSON VON ROSEN ◽  
L. GOTHEFORS ◽  
S. SCHMEISSER ◽  
A. TÄRNVIK ◽  
C. SVANBORG EDÉN

Sign in / Sign up

Export Citation Format

Share Document